USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ENVIVO PHARMACEUTICALS, INC.
Address:
ENVIVO PHARMACEUTICALS, INC.
3696 HAVEN AVE, STE B
REDWOOD CITY, CA 94063
Phone:
(650) 474-2210
URL:
N/A
EIN:
760680844
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $182,621.00 2

Award List:

THE PRIMARY OBJECTIVE OF THIS PROJECT IS TO PROVIDE A NOVEL HEPARIN-LIKE MOLECULAR COMPONENT FOR SMALL BLOOD VESSEL PROSTHESES THAT WILL SIMULTANEOUSLY REDUCE OR PREVENT PERI- ANASTOMOTIC HYPERPLASIA AND REDUCE THROMBOGENICITY.

Award Year / Program / Phase:
1986 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Murial m lippman , PRINCIPAL INVESTIGATOR
Abstract:
The primary objective of this project is to provide a novel heparin-like molecular component for small blood vessel prostheses that will simultaneously reduce or prevent peri- anastomotic hyperplasia and reduce thrombogenicity. the immediate specific aim is to obtain a new supply of this material… More

A NEW METHOD OF DRUG DISCOVERY FOR CNS DISEASES

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$132,621.00
Agency:
HHS
Principal Investigator:
David Lowe
Abstract:
DESCRIPTION (provided by applicant): The discovery and development of small molecule therapeutics for disorders of the Central Nervous System (CNS), particularly for neurodegenerative diseases, is one of the major challenges of modern biomedical research. Although great advances have been made in… More